Jayne E Chisholm

• Merck acquired Acceleron Pharma
• I remained with my branded product
• I also promote 2 Merck products in the oncology space

• launched Reblozyl for 2 indications for rare hematolologic disease.
• gained rapid formulary approval and pathway inclusion in large academic institutions.
• maintaining 2nd largest volume sales in US and highest number of accounts.
• working collaboratively with big pharma co-promotion team
• have gained expertise in virtual promotion strategies throughout pandemic.

President’s award 2016

Responsible for Lilly’s complete Oncology portfolio within key academic institutions: Dana Farber Cancer Institute, Massachusetts General Cancer Center and Smilow Cancer Hospital @ Yale.

Key therapeutic areas include Breast, Thoracic, Gastric, Head and Neck, Colorectal and Liver.

Successfully launched 7 new product indications.

Work collaboratively with Lilly team to project One Lilly.

Creator of innovative customer support/ Account Entry tool, Lilly Moments

• 2007 Vice President's Award Recipient
• 2008 Vice President's Award Recipient
• Promoted spectrum of asthma/allergy products to Pediatricians, Pulmonologists, Otolaryngologists and Allergists throughout the Boston area
• Demonstrated leadership by serving as district Change Agent and designated mentor to teammates
• Success achieved by focusing on Asthma Awareness initiatives and education

• Advocate Development Award 2003
• Identify and cultivate Thought Leader relationships in the area of Supportive Care for key cancer types throughout New England
• Helped to develop scientific platform upon which I built advocacy for the successful launch of Emend
• Developed institutional strategic plans for targeted accounts
• Guest mentor at Sales Training August 2005
• Planned and executed successful Emend Launch Symposium for the Boston Medical Community

• 1999 Vice President's Award Recipient
• Promoted Cardiology specialty product, Aggrastat, to Boston Academic Institutions and other select accounts within New England
• Achieved 171% of Aggrastat sales objective in 1999 holding the largest market share in the nation at 47%
• designed and implemented numerous innovative educational programs e.g. Fellows' Lecture Series, Network Collaboration Dinners
• Coach and Mentor for Merck Trainees

• Pre-launch and Launch activities for Niaspan to Cardiologists in the Boston area

• Promoted Retavase, thrombolytic agent to Boston academic Institutions
• Achieved formulary acceptance at 4 key institutions which in turn lead to acceptance at all local community hospitals. Pull through via educational programs, advocacy and clinical in-services increased sales > 200%
• Sales Training Internship November 1996

• Promoted home infusion and respiratory services to medical community throughout Boston Northeastern MA and NH

• Generated sales of over $1Million promoting specialty home infusion services to hospital based physicians throughout New England, primarily Hemophilia Centers

• Promoted multi-faceted pharmaceutical and diagnostic product line to community based physicians in Massachusetts and RI
• Launched two new antibiotics into highly competitive markets yielding achievement of 120% of quota in 6 months
• Awarded for highest volume sales of Rapid Assay Test

• Ensure proper handling and support of over 30 Scientific Thought Leaders in Melanoma and Supportive Care throughout New England and Upstate NY
• Assessment and development of scientific advocacy among Thought Leaders and key stakeholders within academic institutions
• Served on internal committee for Cancer Immunology training curriculum and implementation within HSC team. These efforts resulted in praise from Scientific community on the depth of understanding and scientific engagement regarding cutting edge oncologic concepts
• Speaker Management